Revelation Biosciences, Inc. (REVBW) — DEF 14A Filings
All DEF 14A filings from Revelation Biosciences, Inc.. Browse 5 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (5)
-
Revelation Biosciences Seeks Shareholder Nod for Warrant Issuance
— Nov 10, 2025 Risk: medium
Revelation Biosciences, Inc. (REVBW) is holding a Special Meeting of Stockholders on December 3, 2025, to vote on a critical proposal: the approval of reserving -
Revelation Biosciences Seeks Share Issuance Approval for Warrants
— Sep 22, 2025 Risk: medium
Revelation Biosciences, Inc. (REVBW) is holding a Special Meeting on October 15, 2025, to seek stockholder approval for the reservation and issuance of common s -
Revelation Biosciences Seeks Equity Plan Changes, Director Election
— Jun 9, 2025 Risk: medium
Revelation Biosciences, Inc. (REVBW) filed a DEF 14A on June 9, 2025, outlining proposals for its virtual Annual Meeting on June 23, 2025, at 10:00 a.m. Eastern -
Revelation Biosciences Files Definitive Proxy Statement
— Dec 16, 2024 Risk: low
Revelation Biosciences, Inc. filed a definitive proxy statement (DEF 14A) on December 16, 2024, for its fiscal year ending December 31, 2024. The company, forme -
Revelation Biosciences Announces 2024 Annual Meeting of Stockholders on May 15
— Apr 16, 2024 Risk: low
REVELATION BIOSCIENCES, INC. (REVBW) filed a Proxy Statement (DEF 14A) with the SEC on April 16, 2024. The 2024 Annual Meeting of Stockholders for Revelation Bi
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX